ISDA: 8Y0V

Deposition Date 2024-01-23

Release Date 2024-12-18

Last Version Date 2025-11-26

Entry Detail

PDB ID:

8Y0V

Keywords:

IMMUNE SYSTEM

Title:

HIF prolyl hydroxylase 2 in complex with inhibitor

Biological Source:

Source Organism(s):

Homo sapiens (Taxon ID: 9606)

Expression System(s):

Escherichia coli bl21(de3)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.50 Å

R-Value Free:

0.29

R-Value Work:

0.22

Space Group:

P 63

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Egl nine homolog 1
Gene (Uniprot):EGLN1
Chain IDs:A
Chain Length:246
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9GZT9 Pfam ID:PF13640 EC:1.14.11.2

Ligand Molecules

A1D5X

Primary Citation

Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor.

Fu, Y, Ding, X, Zhang, M, Feng, C, Yan, Z, Wang, F, Xu, J, Lin, X, Ding, X, Wang, L, Fan, Y, Li, T, Yin, Y, Liang, X, Xu, C, Chen, S, Pulous, F.E, Gennert, D, Pun, F.W, Kamya, P, Ren, F, Aliper, A, Zhavoronkov, A.Show

Nat.Biotechnol. 43 1772 1777 (2025)

PMID: 39663371 DOI: 10.1038/s41587-024-02503-w

Abstact

Hypoxia-inducible factor prolyl hydroxylase (PHD) inhibitors have been approved for treating renal anemia yet have failed clinical testing for inflammatory bowel disease because of a lack of efficacy. Here we used a multimodel multimodal generative artificial intelligence platform to design an orally gut-restricted selective PHD1 and PHD2 inhibitor that exhibits favorable safety and pharmacokinetic profiles in preclinical studies. ISM012-042 restores intestinal barrier function and alleviates gut inflammation in multiple experimental colitis models.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form